Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells

被引:463
|
作者
Moriggl, R
Topham, DJ
Teglund, S
Sexl, V
McKay, C
Wang, D
Hoffmeyer, A
van Deursen, J
Sangster, MY
Bunting, KD
Grosveld, GC
Ihle, JN
机构
[1] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA
[5] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
[6] Univ Tennessee, Sch Med, Dept Biochem, Memphis, TN 38063 USA
关键词
D O I
10.1016/S1074-7613(00)80025-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many cytokines activate two highly homologous Stat proteins, 5a and 5b. Mice deficient in both genes lack all growth hormone and prolactin functions but retain functions associated with cytokines such as erythropoietin. Here, we demonstrate that, while lymphoid development is normal, Stat5a/b mutant peripheral T cells are profoundly deficient in proliferation and fail to undergo cell cycle progression or to express genes controlling cell cycle progression. In addition, the mice lack NK cells, develop splenomegaly, and have T cells with an activated phenotype, phenotypes seen in IL-2 receptor beta chain-deficient mice. These phenotypes are not seen in mice lacking Stat5a or Stat5b alone. The results demonstrate that the State proteins, redundantly, are essential mediators of IL-2 signaling in T cells.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条
  • [1] A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance
    Goleva, E
    Kisich, KO
    Leung, DYM
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (10): : 5934 - 5940
  • [2] Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGFβ is reversed by IL-15
    Campbell, JDM
    Cook, G
    Robertson, SE
    Fraser, A
    Boyd, KS
    Gracie, JA
    Franklin, IM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (01): : 553 - 561
  • [3] Regulation of cell growth by IL-2: Role of STAT5 in protection from apoptosis but not in cell cycle progression
    Zamorano, J
    Wang, HY
    Wang, R
    Shi, Y
    Longmore, GD
    Keegan, AD
    [J]. JOURNAL OF IMMUNOLOGY, 1998, 160 (07): : 3502 - 3512
  • [4] IL-6 activates STAT5 in T cells
    Tormo, Aurelie Jeanne
    Letellier, Marie-Claude
    Sharma, Mukut
    Elson, Greg
    Crabe, Sandrine
    Gauchat, Jean-Francois
    [J]. CYTOKINE, 2012, 60 (02) : 575 - 582
  • [5] Assessing IL-2-Induced STAT5 Phosphorylation in Fixed, Permeabilized Foxp3+ Treg Cells by Multiparameter Flow Cytometry
    Li, Can
    Park, Jung-Hyun
    [J]. STAR PROTOCOLS, 2020, 1 (03):
  • [6] ACTIVATED STAT5 DRIVES PERIPHERAL T CELL LYMPHOMAS
    Maurer, B.
    Nivarthi, H.
    Prchal-Murphy, M.
    Wingelhofer, B.
    Chen, D.
    Winkler, S.
    Schlederer, M.
    Pham, H. T. T.
    Kenner, L.
    Sexl, V.
    Kolbe, T.
    Kralovics, R.
    Mueller, M.
    Ruelicke, T.
    Moriggl, R.
    [J]. HAEMATOLOGICA, 2016, 101 : 567 - 567
  • [7] IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells
    Burchill, Matthew A.
    Yang, Jianying
    Vogtenhuber, Christine
    Blazar, Bruce R.
    Farrar, Michael A.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 280 - 290
  • [8] STAT5 inhibition induces apoptosis in peripheral T cell lymphoma
    Simpson, Haley M.
    Furusawa, Aki
    Sadashivaiah, Kavitha
    Banerjee, Arnob
    [J]. CANCER RESEARCH, 2017, 77
  • [9] STAT5 is essential for sustained activation of the PI3 kinase pathway during IL-2-induced lymphocyte proliferation
    Tran, Eric
    Lockyer, Heather
    Nelson, Brad
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S28 - S28
  • [10] Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes:: Role of cyclic adenosine 3',5'-monophosphate and phosphatases
    Zhang, H
    Conrad, DM
    Butler, JJ
    Zhao, CL
    Blay, J
    Hoskin, DW
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (02): : 932 - 944